Search

everythinglearnresearchcommunity

for

Search:↓

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Alopecia areata treatment varies, with no optimal method established yet.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Effective treatments for severe alopecia areata are still lacking.

Low vitamin D levels are common in people with Alopecia Areata.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Certain gene variations increase the risk of alopecia areata in Koreans.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The Hairless gene is crucial for hair cell development, affecting whether skin cells become hair or skin and oil gland cells.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Hair loss treatment caused more hair loss in a man.

A patient with total hair loss developed vitiligo after using a treatment called DCP.